Skip to main content

Table 1 Baseline demographic, anthropometric and clinical data of episodic migraine patients in a randomized controlled trial of vitamin D vs. placebo

From: The effects of vitamin D3 supplementation on TGF-β and IL-17 serum levels in migraineurs: post hoc analysis of a randomized clinical trial

 

Vitamin D (n = 40)

Placebo (n = 40)

P valuea

Age (year)

37 (8)

38 (12)

0.819

Headache Onset years (year)

12 (8)

11 (8)

0.679

Body mass index (kg/m2)

25.83 (4.07)

25.36 (4.29)

0.613

Sex

Female

32 (80.0%)

32 (80.0%)

1.000

Male

8 (20.0%)

8 (20.0%)

  1. Values are expressed as mean (standard deviation (SD)) or number (%) as appropriate
  2. aUsing either Independent t test or Chi square according to the type of data
  3. This data are identical to our previously reported data [10, 31]